GOLDMAN SACHS GROUP INC - INSTIL BIO INC ownership

INSTIL BIO INC's ticker is TIL and the CUSIP is 45783C101. A total of 63 filers reported holding INSTIL BIO INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of INSTIL BIO INC
ValueSharesWeighting
Q3 2023$13,577
-28.9%
31,721
-8.4%
0.00%
Q2 2023$19,086
-93.4%
34,639
-92.1%
0.00%
Q1 2023$288,611
-11.1%
436,759
-15.2%
0.00%
Q4 2022$324,609
-74.9%
515,253
+92.6%
0.00%
Q3 2022$1,294,000
+12.0%
267,500
+7.0%
0.00%
Q2 2022$1,155,000
+24.3%
249,950
+189.2%
0.00%
Q1 2022$929,000
-33.6%
86,430
+5.7%
0.00%
Q4 2021$1,399,000
+632.5%
81,772
+667.2%
0.00%
Q3 2021$191,000
-93.5%
10,659
-91.0%
0.00%
-100.0%
Q1 2021$2,957,000117,8850.00%
Other shareholders
INSTIL BIO INC shareholders Q2 2021
NameSharesValueWeighting ↓
Curative Ventures V LLC 37,980,073$16,255,471100.00%
CPMG Inc 8,218,467$3,517,5041.92%
Western Standard LLC 1,796,987$769,1100.70%
Vivo Capital, LLC 12,486,787$5,344,3450.59%
Nantahala Capital Management 1,000,000$428,0000.04%
Baker Brothers Advisors 4,704,395$2,013,4810.01%
HCR Wealth Advisors 40,000$17,1200.00%
Hennion & Walsh Asset Management, Inc. 98,080$41,9780.00%
Long Focus Capital Management, LLC 100,000$42,8000.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 867,279$371,1950.00%
View complete list of INSTIL BIO INC shareholders